Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO).

Saved in:
Bibliographic Details
Title: Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO).
Authors: Padovan, Marta1 (AUTHOR) marta.padovan@iov.veneto.it, Eoli, Marica2 (AUTHOR) marica.eoli@istituto-besta.it, Pellerino, Alessia3 (AUTHOR) alessia.pellerino@unito.it, Rizzato, Simona4 (AUTHOR) simona.rizzato@asufc.sanita.fvg.it, Caserta, Claudia5 (AUTHOR) caserta_claudia@libero.it, Simonelli, Matteo6,7 (AUTHOR) matteo.simonelli@hunimed.eu, Michiara, Maria8 (AUTHOR) Michiara@ao.pr.it, Caccese, Mario1 (AUTHOR) mario.caccese@iov.veneto.it, Anghileri, Elena2 (AUTHOR) elena.anghileri@istituto-besta.it, Cerretti, Giulia1 (AUTHOR) giulia.cerretti@iov.veneto.it, Rudà, Roberta3,9 (AUTHOR) roberta.ruda@aulss2.veneto.it, Zagonel, Vittorina1 (AUTHOR) vittorina.zagonel@iov.veneto.it, Lombardi, Giuseppe1 (AUTHOR) giuseppe.lombardi@iov.veneto.it
Source: Cancers. Jun2021, Vol. 13 Issue 11, p2773. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers13112773